Navigation Links
Islet cells producing insulin cultivated in the lab

Now there is an answer, not to far, to the complexities of Type I diabetics and insulin injections. This is according to researchers at the University of Calgary whose bioengineering team announced //that they have developed a way of growing pancreatic cells in their laboratory.

In the words of Dr. Leo Behie, “This is a significant milestone on the path to effectively producing human tissue that may be used to treat Type 1 diabetes. There is a huge international push to find a human pancreatic cell source — a Holy Grail of sorts — that could be used for transplantation," he said. "Once it is found, our lab will be ready to grow these cells in a clinically acceptable manner."

Behie and colleagues reported they have cultured human cells that are believed to be good candidates for generating islet cells that can make insulin.

The successful growth and characterization of these functional islet cells in the lab led to the conclusion that they may be suitable for treating individuals with Type 1 diabetes. Happy at this feat Donna Lillie of the Canadian Diabetes Association said, "This is very encouraging news for people with Type 1 diabetes who look forward to a future without this serious condition."

Scientists at the University of Alberta in Edmonton were the first to successfully transplant islet cells into people with diabetes in 2000, freeing them from insulin injections.

The bottleneck with this study as of now is that it takes pancreas cells from as many as three donor cadavers to supply enough for one patient transplant. Still it is an excellent beginning and paves way for breakthrough treatment of Type I diabetes


'"/>




Page: 1

Related medicine news :

1. Islets May Lead to Diabetes Cure
2. Islet Cells May Lead to Diabetes CureChildren
3. MRI Can Monitor Transplanted Islets
4. Islet cell transplants for Type 1 Diabetes
5. Successful Islet Cell Transplant in Mice With Type 1 Diabetes
6. LCT Reports Major Step for Islet Transplantation in Diabetes Patient
7. Action of nerve cells
8. Therapy for stopping the spread of cancer cells
9. Hydroxyurea derivatives kill colon cancer cells
10. Creating brain cells from bone marrow
11. A Chinese herb kills cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology: